Hsp 90 inhibitors (Walter and Eliza Hall Institute)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHsp 90 inhibitors (Walter and Eliza Hall Institute)
Drug Alias NameHsp 90 inhibitors (Walter and Eliza Hall Institute)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 inhibitors
TargetsHeat shock protein HSP90
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWalter And Eliza Hall Institute Of Medical Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWalter And Eliza Hall Institute Of Medical Research
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A